UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2

Ecancermedicalscience, 2022-09, Vol.16

2022

Link zum Volltext

Verfügbarkeit prüfen

Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina

Ecancermedicalscience, 2021-11, Vol.15, p.1312-1312

2021

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report

JTO clinical and research reports, 2023-02, Vol.4 (2), p.100456, Article 100456

2023

Link zum Volltext

Verfügbarkeit prüfen

PP.05 Access to Genomic Testing and Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Single-Institution Study

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.S10-S11

2023

Link zum Volltext

Verfügbarkeit prüfen

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients

Cancer Immunology, Immunotherapy, 2019-10, Vol.68 (10), p.1585-1596

2019

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Nivolumab in Resectable Lung Cancer

The New England journal of medicine, 2024-05, Vol.390 (19), p.1756-1769

2024

Link zum Volltext

Verfügbarkeit prüfen

PP.50 Implementation of an Institutional Lung Cancer Screening Program Using Low-Dose Computed Tomography in Argentina

Journal of thoracic oncology, 2023-03, Vol.18 (3), p.S28-S29

2023

Link zum Volltext

Verfügbarkeit prüfen

Assessment of early response to imatinib 800 mg after 400 mg progression by

Future oncology (London, England), 2015-03, Vol.11 (6), p.953-964

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of early response to imatinib 800 mg after 400 mg progression by .sup.18F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Future oncology (London, England), 2015-03, Vol.11 (6), p.953

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of early response to imatinib 800 mg after 400 mg progression by ^sup 18^F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Future oncology (London, England), 2015-03, Vol.11 (6), p.953-964

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of early response to imatinib 800 mg after 400 mg progression by 18 F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Future oncology (London, England), 2015-03, Vol.11 (6), p.953-964

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Future oncology (London, England), 2015, Vol.11 (6), p.953-964

2015

Link zum Volltext

Verfügbarkeit prüfen

Surgically treated bronchopulmonary carcinoid tumours. Prognostic value of TNM staging 7a edition

Medicina (Buenos Aires), 2014, Vol.74 (6), p.437-442

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract C31: Phase 1 study of AV-412, a novel irreversible EGFR inhibitor, administered daily in patients with advanced solid tumors

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.C31-C31

2009

Link zum Volltext

Verfügbarkeit prüfen

High-risk human papilloma virus infection, tumor pathophenotypes, and and status in juvenile breast cancer

Breast cancer research and treatment, 2009-10, Vol.122 (3), p.671-683

2009

Link zum Volltext

Verfügbarkeit prüfen

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report

JTO clinical and research reports, 2023, Vol.4 (2), p.100456-100456

2023

Link zum Volltext

Verfügbarkeit prüfen

Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2

Ecancermedicalscience, 2022, Vol.16, p.1448-1448

2022

Link zum Volltext

Verfügbarkeit prüfen

Tumores carcinoides pulmonares tratados quirúrgicamente valor pronóstico de la 7ª estadificación TNM

Medicina (Buenos Aires), 2014-12, Vol.74 (6), p.437-442

2014

Link zum Volltext

Verfügbarkeit prüfen

Utilidad del cisplatino intrapericárdico en el tratamiento del derrame pericárdico maligno

Revista argentina de cardiología, 2010-04, Vol.78 (2), p.114-117

2010

Link zum Volltext

Verfügbarkeit prüfen

El aprendizaje iniciático del caballero

Bibliografía de la Literatura Española (BLE)- unstructured, 2005

2005

Link zum Volltext

Verfügbarkeit prüfen

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(13)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Oncology
(7)
Humans
(5)
Life Sciences & Biomedicine
(5)
Male
(5)
Science & Technology
(5)
Aged
(4)
Female
(4)
Middle Aged
(4)
Mutation
(4)
Adult
(3)
Cancer Therapies
(3)
Clinical Trials
(3)
Lung Cancer
(3)
Lung Neoplasms - Pathology
(3)
Patients
(3)
Breast Cancer
(2)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(2)
Carcinoma, Non-Small-Cell Lung - Pathology
(2)
Chemotherapy
(2)
Immunotherapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2

Association of PD‐L1 expression with driver gene mutations and clinicopathological characteristics in non‐small cell lung cancer: A real‐world study of 10 441 patients

Implementation of a molecular tumour board in LATAM: the impact on treatment decisions for patients evaluated at Instituto Alexander Fleming, Argentina

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report

PP.05 Access to Genomic Testing and Targeted Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Single-Institution Study

Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients

Perioperative Nivolumab in Resectable Lung Cancer

PP.50 Implementation of an Institutional Lung Cancer Screening Program Using Low-Dose Computed Tomography in Argentina

Assessment of early response to imatinib 800 mg after 400 mg progression by

Assessment of early response to imatinib 800 mg after 400 mg progression by .sup.18F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Assessment of early response to imatinib 800 mg after 400 mg progression by ^sup 18^F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Assessment of early response to imatinib 800 mg after 400 mg progression by 18 F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors

Surgically treated bronchopulmonary carcinoid tumours. Prognostic value of TNM staging 7a edition

Abstract C31: Phase 1 study of AV-412, a novel irreversible EGFR inhibitor, administered daily in patients with advanced solid tumors

High-risk human papilloma virus infection, tumor pathophenotypes, and and status in juvenile breast cancer

Overcoming Resistance to Osimertinib by T790M Loss and C797S Acquisition Using Gefitinib in a Patient With EGFR-Mutant NSCLC: A Case Report

Precision medicine in the real-world setting. Clinical activity of talazoparib in a woman with hormone receptor-positive HER2-negative metastatic breast cancer with pathogenic mutation in somatic BRCA2

Tumores carcinoides pulmonares tratados quirúrgicamente valor pronóstico de la 7ª estadificación TNM

Utilidad del cisplatino intrapericárdico en el tratamiento del derrame pericárdico maligno

El aprendizaje iniciático del caballero

Suchergebnisse filtern